Reduced critical concentration might not have improved MGIT-based DST’s sensitivity to rifampicin-Reference-Cited by-同舟云学术

Reduced critical concentration might not have improved MGIT-based DST’s sensitivity to rifampicin

Published:2024-05-02 Issue:5 Volume:68 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Rupasinghe Praharshinie¹²^ORCID,Ashraf Azka³,Barreda Nadia⁴,Parveen Shafiqua³,Zubair Muhammad³,Calderon Roger⁴^ORCID,Asif Sunil³,Hirani Nilma⁵,Chingisova Layila⁶,Bulane Atang⁷,Hang Pham Thu⁸,Ha Doan Thu⁹,Ardizzoni Elisa¹^ORCID,Kursheed Nazia³,De Rijk Willem Bram¹,Rigouts Leen¹²^ORCID,Guglielmetti Lorenzo¹⁰¹¹¹²,Mitnick Carol¹³¹⁴¹⁵,de Jong Bouke C.¹

Affiliation:

1. Unit of Mycobacteriology, Institute of Tropical Medicine, Antwerp, Belgium

2. Department of Biomedical Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium

3. The Indus Hospital laboratory, Karachi, Pakistan

4. Socios en Salud, Lima, Peru

5. Department of Microbiology, Sir JJ Hospital, Mumbai, India

6. National Tuberculosis Reference Lab, Almaty, Kazakhstan

7. Center for Tuberculosis, National Institute of Communicable Diseases, Mohakhali, South Africa

8. Regional Tuberculosis Reference Lab, Ho Chi Minh, Vietnam

9. National Tuberculosis Reference Lab, Hanoi, Vietnam

10. Medical Department, MSF, Paris, France

11. Sorbonne University, Centre d’Immunologie et des Maladies Infectieuses (Cimi-Paris), Paris, France

12. AP-HP, Bactériologie-Hygiène, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries, Paris, France

13. Brigham and Women's Hospital, Boston, Massachusetts, USA

14. Partners In Health, Boston, Massachusetts, USA

15. Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA

Funder

Médecins Sans Frontières

Publisher

American Society for Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01701-23

Reference6 articles.

1. Mechanisms and detection methods of Mycobacterium tuberculosis rifampicin resistance: The phenomenon of drug resistance is complex

2. Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard

3. Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results

4. Discordant results between genotypic and phenotypic assays (Xpert MTB/RIF vs. BACTEC MGIT 960 system) for detection of RIF-resistant Mycobacterium tuberculosis isolates in a high burden region

5. Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown